News for IR-Med Inc. (IRME)

Rosh Pina, Israel, March 18, 2025 (GLOBE NEWSWIRE) -- IR-MED Inc. (”œIR-MED” or the ”œCompany”) ( IRME), a developer of noninvasive, AI-driven spectrogr

Patient enrollment and monitoring with PressureSafe™ has commencedIn a similar study conducted at the world’s 2nd largest HMO, PressureSafe™ had efficacy...

Rosh Pina, Israel, Aug. 28, 2024 (GLOBE NEWSWIRE) -- IR-MED Inc., (“IR-MED” or the “Company”) (OTCQB:IRME), developer of a noninvasive artificial...

Rosh Pina, Israel, Aug. 21, 2024 (GLOBE NEWSWIRE) -- IR-MED Inc., (“IR-MED” or the “Company”) (OTCQB:IRME), developer of a noninvasive artificial...

DiaSafe™, IR-MED’s second product, is being developed to provide safe, real-time optical readings of biomarkers to detect the early presence of diabetic...

Poster presentation available here: LINK Rosh Pina, Israel, May 22, 2024 (GLOBE NEWSWIRE) -- IR-MED Inc., (“IR-MED” or the “Company”) (OTCQB:IRME),...

By Thomas Kerr, CFA

Marks major milestone prior to launch in U.S. marketPressureSafe™ scanner and disposable pack both listed with FDAPressureSafe™ can support early detection...

Incidence of pressure injuries reduced by 50% during the study periodAs a decision support device, PressureSafe, can support early detection of pressure...

Final results to be reported from a study conducted at two medical centers owned by Clalit, the world’s second largest health maintenance organization...

PressureSafe, for the early detection of pressure injuries, addresses a healthcare challenge that costs $26.8 billion and causes 60,000 deaths annually in...

Dr. Dalton brings decades of experience as a hall of fame CEO, entrepreneur, pharmaceutical executive and founder of over 40 companies Rosh Pinna,...